Bhatu R Patil

1PUBLICATIONS
5CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Sep 08, 2025
Lazertinib: A Cardio-Safer Alternative to Osimertinib for Epidermal Growth Factor Receptor L858R/T790M Double-Mutant Tyrosine Kinase Resistant Non-Small Cell Lung Cancer.

Chandrakant S Gawli, Narendra R Nagpure, Bhatu R Patil

Pageof 1

Frequent Collaborators

1 joint publications

Chandrakant S Gawli

1 joint publications

Narendra R Nagpure

1 joint publications

Nobuaki Ochi

1 joint publications

Nagio Takigawa